Radiomics based on pretreatment MRI for predicting distant metastasis of nasopharyngeal carcinoma: A preliminary study
暂无分享,去创建一个
Fang Wang | Tongxing Liu | Haitao Jiang | Wujie Chen | F. Jiang | F. Lu | Yuguo Wei | W. Qin | Y. Tan | Ting-Ting Jiang | S. Nan
[1] J. Bei,et al. Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. , 2022, European journal of cancer.
[2] W. Pei,et al. MRI‐Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma , 2021, Journal of magnetic resonance imaging : JMRI.
[3] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[4] A. Rahmim,et al. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal 18F-FDG PET/CT images , 2018 .
[5] L. Mainardi,et al. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients , 2020, Cancers.
[6] D. Dong,et al. MRI‐Based Deep‐Learning Model for Distant Metastasis‐Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma , 2020, Journal of magnetic resonance imaging : JMRI.
[7] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[8] Richard Du,et al. Effect of machine learning re-sampling techniques for imbalanced datasets in 18F-FDG PET-based radiomics model on prognostication performance in cohorts of head and neck cancer patients , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[9] A. Rahmim,et al. Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images , 2019, Molecular Imaging and Biology.
[10] Ying Sun,et al. Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma , 2019, Clinical Cancer Research.
[11] Ying Sun,et al. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups , 2019, European Radiology.
[12] D. Dong,et al. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study , 2019, EBioMedicine.
[13] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[14] Ying Sun,et al. RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma , 2018, Clinical Cancer Research.
[15] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[16] Andriy Fedorov,et al. Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.
[17] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[18] D. Dong,et al. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma , 2017, Clinical Cancer Research.
[19] R. Weber,et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy , 2016, Cancer.
[20] Jianji Pan,et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial , 2016, The Lancet.
[21] N. Lee,et al. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. , 2016, Oral oncology.